TABLE 2.
Characteristics | Vitek2 GP IDa |
Api/ID32 Staphb | Vitek GP IDc | Manual testsd | Manual testse | ||
---|---|---|---|---|---|---|---|
Total strains | Human strains (n = 14) | Animal strains (n = 13) | |||||
Biochemical characteristics | |||||||
d-amygdalin | 3.7 | 7.1 | 0 | ||||
Optochin resistance | 96.3 | 100 | 92.3 | ||||
l-lactate alkalinisation | 70.4 | 71.4 | 69.2 | ||||
O129 resistance | 92.6 | 85.7 | 100 | ||||
Polymyxin B resistance | 3.1 | 7.1 | 0 | ||||
Arginine dihydrolase 2 | 11.1 | 0 | 23.1f | ||||
Bacitracin resistance | 74.1 | 78.6 | 69.2 | ||||
Lactose | 51.9 | 50.0 | 53.8 | 19 | 27 | 95 | 50 |
d-mannitol | 70.4 | 71.4 | 69.2 | 77 | 87 | 95 | 95 |
Arginine dihydrolase 1 | 85.2 | 85.7 | 84.6 | 96 | 100 | 100 | 100 |
Urease | 74.1 | 92.9 | 53.8f | 85 | 93% H+/CCM− | 90 | 92 |
d-mannose | 77.8 | 78.6 | 76.9 | 88 | 87 | 95 | |
Saccharose/sucrose | 0 | 0 | 0 | 93 | 27 | 95 | |
Beta-galactosidase | 14.8 | 21.4 | 7.7 | 4 | 0 | ||
l-pyrrolidonyl-arylamidase | 74.1 | 71.4 | 76.9 | 81 | 100 | 100 | |
d-maltose | 22.2 | 42.9 | 0.0f | 65 | 93% H+/CCM− | 100 | 89 |
d-trehalose | 63.0 | 71.4 | 53.8 | 96 | 100 | 90 | 97 |
Phosphatase | 22.2 | 28.6 | 15.4 | 93 | 92 | ||
d-galactose | 44.4 | 35.7 | 53.8 | 53 | 71 |
Information obtained from this study (n = 27).
Information obtained from Vandenesch et al. (22) (n = 24). Eight clinical plus 16 animal strains (including CCM3573).
Information obtained from Shuttleworth et al. (7) (n = 14). Fourteen clinical strains: human (H) plus CCM3573 (CCM).
Information obtained from Kawamura et al. (24) (n = 60). All strains were of human origin.
Information obtained from Behme et al. (23) (n = 38). Strains were of diverse origin (human, animal, environment).
Biochemical characteristics with a statistically significant difference (P < 0.05).